ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Neuronal Signaling >AChR antagonist >Fesoterodinefumarate

Fesoterodinefumarate

Fesoterodinefumarate Structure
CAS No.
286930-03-8
Chemical Name:
Fesoterodinefumarate
Synonyms
Toviaz;CS-102;CS-244;SPM 907;Spm 8272;SMP 8272;Unii-eos72165S7;Fesoterodinefumarate;PF-00695838 fumarate;Fesoterodine maleate
CBNumber:
CB51075581
Molecular Formula:
C30H41NO7
Molecular Weight:
527.65
MOL File:
286930-03-8.mol
MSDS File:
SDS
Modify Date:
2024/11/19 15:53:33

Fesoterodinefumarate Properties

Melting point 72-78°C
storage temp. Inert atmosphere,2-8°C
solubility DMSO (Slightly), Ethanol (Slightly), Methanol (Slightly)
form Solid
color White to Off-White
Stability Hygroscopic

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07,GHS08
Signal word  Warning
Hazard statements  H302-H361-H402-H319
Precautionary statements  P201-P202-P281-P308+P313-P405-P501-P264-P280-P305+P351+P338-P337+P313P-P264-P270-P301+P312-P330-P501
NFPA 704
0
2 0

Fesoterodinefumarate Chemical Properties,Uses,Production

Chemical Properties

White Solid

Drug interactions

Potentially hazardous interactions with other drugs
 Anti-arrhythmics: increased risk of antimuscarinic side effects with disopyramide.
 Antifungals: dose reduction advised with itraconazole and ketoconazole.
 Antivirals: dose reduction advised with atazanavir, indinavir, ritonavir and saquinavir.
 Induction of CYP3A4 may lead to subtherapeutic plasma levels. Concomitant use with CYP3A4 inducers (e.g. carbamazepine, rifampicin, phenobarbital, phenytoin, St John's Wort) is not recommended.
 Co-administration of a potent CYP2D6 inhibitor may result in increased exposure and adverse events. A dose reduction to 4 mg may be needed' 

Metabolism

Rapidly and extensively hydrolysed to its active metabolite. The active metabolite is further metabolised in the liver to its carboxy, carboxy-N-desisopropyl, and N-desisopropyl metabolites via two major pathways involving CYP2D6 and CYP3A4. None of these metabolites contribute significantly to the antimuscarinic activity of fesoterodine. Approximately 70% of an oral dose of fesoterodine is recovered in the urine as metabolites, and a smaller amount in the faeces.

Fesoterodinefumarate Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 238)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Lupin Ltd +91-8019896181 +91-8019896181 Maharashtra, India 93 58 Inquiry
Alembic Pharmaceuticals Limited +91-2652280880 +91-2652280550 Gujarat, India 115 58 Inquiry
Ralington Pharma +91-7948911722 +91-9687771722 Gujarat, India 1350 58 Inquiry
BDR Pharmaceuticals International Pvt Ltd +91-2240560560 +91-7718884418 Maharashtra, India 206 58 Inquiry
Raks Pharma Pvt Ltd +91-8924671555 +91-8924671555 AndhraPradesh, India 31 58 Inquiry
Pharma Affiliates 172-5066494 Haryana, India 6754 58 Inquiry
Manus Aktteva +91 (79) 6512-3395 New Delhi, India 581 34 Inquiry
ALEMBIC PHARMACEUTICALS LTD +91 40 23704923 / 24 / 25 New Delhi, India 108 58 Inquiry
LUPIN LTD +91 124 4885000 / +91 124 3325000 New Delhi, India 191 58 Inquiry
WOCKHARDT BIO AG New Delhi, India 8 58 Inquiry

Fesoterodinefumarate Spectrum

(R)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl isobutyrate fumarate (R)-Fesoterodine fumarate 2-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl 2-methylpropanoate fumarate (R)-2-(3-(Diisopropylamino)-1-phenylpropyl)-4-methoxyphenyl isobutyrate fumarate Fesoterodine maleate 2-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl 2-methylpropanoate fumarate Propanoic acid, 2-methyl-, 2-((1R)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl ester, (2E)-2-butenedioate (1:1) (salt) Spm 8272 Toviaz Unii-eos72165S7 Fesoterodinefumarate (R)-Fesoterodine Fumarate 2-Methylpropanoic Acid 2-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl Ester (2E)-2-Butenedioate SMP 8272 SPM 907 FESOTERODINE MALEATE INTERMEDIATES Fesoterodine fuMarate (Toviaz) 2-((1R)-3-(Diisopropylamino)-1-phenylpropyl)-4(hydroxymethyl)phenyl isobutyrate Fesoterodine fuMarate salt PF-00695838 fumarate Fesoterodine-fumarlate-d7 [2-[(1R)-3-(Di(propan-2-yl)amino)-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate fumarate Fesoterodine maleate (Toviaz) CS-102 CS-244 Fesoterodinefumarate USP/EP/BP Fesoterodine fumarateQ: What is Fesoterodine fumarate Q: What is the CAS Number of Fesoterodine fumarate Q: What is the storage condition of Fesoterodine fumarate TIANFUCHEM--Fesoterodinefumarate 2-[(1R)-3-(diisopropylamino)-1-phenyl-propyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate 286930-03-8 C26H37NO3C4H4O4 C30H41NO7 Toviaz Amines Aromatics Intermediates & Fine Chemicals Pharmaceuticals Aromatics Compounds